MA
CVS icon

Mezzasalma Advisors’s CVS Health CVS Stock Holding History

Mezzasalma Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,783
Closed -$2.06M – 83
2024
Q1 		$2.06M Buy
25,783
+22,514
+689% +$1.72M 0.97% 21
2023
Q4 		$258K Buy
+3,269
New +$233K 0.14% 80

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Mezzasalma Advisors's CVS Position: Q2 2024 in Review

Mezzasalma Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 25,783 shares — an estimated $2.06M sold.

Mezzasalma Advisors first reported a position in CVS in Q4 2023 and held it in 2 quarters. The position peaked at $2.06M in Q1 2024. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Mezzasalma Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Mezzasalma Advisors sold 25,783 CVS Health shares in Q2 2024, an estimated $2.06M.
  • Mezzasalma Advisors first reported a position in CVS Health in Q4 2023 and held it in 2 quarters.
  • Mezzasalma Advisors's CVS Health position peaked at $2.06M in Q1 2024.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Mezzasalma Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.